Print Page   |   Contact Us   |   Sign In   |   Join Today
News & Press: General

Eyes on Washington: Federal Health Care Grant Notification Service

Monday, April 6, 2015   (0 Comments)
Posted by: TCAA Staff
Share |

 

Eyes on Washington: Federal Health Care Grant Notification Service

 

Grant Opportunities for March 30, 2015 through April 3, 2015

 

Visit Holland & Knight online

 

New Federal Health Care Grant Opportunities Announced for:

·         Administration for Children and Families (ACF)

·         Administration for Community Living (ACL)

·         Centers for Disease Control and Prevention (CDC)

·         Health Resources and Services Administration (HRSA)

·         Defense Advanced Research Projects Agency (DARPA)

·         National Institutes of Health (NIH)

 

Over the past year, Andrew Conlin has diligently distributed over fifty issues of Holland & Knight’s Federal Health Care Grant Notification Service. However, this issue will be Andrew’s last, as he departs for new and exciting adventures. We wish him the best. Starting next week, Daniel Arking will be taking over distribution of all future issues of the Federal Health Care Grant Notification Service.

 

NON-NIH Funding Opportunity Announcements:

 

ACF: Health Profession Opportunity Grants Serving Low-Income Individuals

Funding Opportunity Number: HHS-2015-ACF-OFA-FX-0951

This Funding Opportunity Announcement (FOA) solicits applications for cooperative agreements to support demonstration projects designed to provide eligible individuals with the opportunity to obtain education and training for occupations in the health care field that pay well and are expected to either experience labor shortages or be in high demand. In addition to providing education and training services, funds for this project may be used for child care, case management, and other supportive services as appropriate. Individuals who are eligible to participate in the Health Profession Opportunity Grants (HPOG) programs are those receiving assistance under a state TANF (Temporary Assistance for Needy Families) program and other low-income individuals. Potential applicants will need to be able to demonstrate strong partnerships with health care employers, and a strong labor market demand for the occupations for which they are providing education and training. All grantees will be required to take part in a rigorous evaluation, which is likely to include a random assignment process of potential participants into control and intervention groups. This funding opportunity was announced on March 30, 2015. The application deadline is May 29, 2015. For more information, please visit ACF's Full Funding Opportunity Announcement.

 

ACF: Health Profession Opportunity Grants for Tribes, Tribal Organizations, and Tribal Colleges or Universities

Funding Opportunity Number: HHS-2015-ACF-OFA-FY-0952

This Funding Opportunity Announcement (FOA) solicits applications for cooperative agreements to support demonstration projects that are designed to provide eligible individuals with the opportunity to obtain education and training for occupations in the health care field that pay well and are expected to either experience labor shortages or be in high demand. In addition to providing education and training services, funds for this project may be used for child care, case management, and other supportive services as appropriate. Individuals who are eligible to participate in the HPOG program are those receiving assistance under a state or tribal Temporary Assistance for Needy Families (TANF) program and other low-income individuals. Potential applicants will need to be able to demonstrate strong partnerships with health care employers, and a strong labor market demand for the occupations for which they are providing education and training. Under this FOA, at least three grants will be issued to eligible entities that are Indian tribes, tribal organizations, or Tribal Colleges or Universities. This funding opportunity was announced on March 30, 2015. The application deadline is May 29, 2015. For more information, please visit ACF's Full Funding Opportunity Announcement.

 

ACL: Empowering Older Adults and Adults with Disabilities through Chronic Disease Self-Management Education Programs

Funding Opportunity Number: HHS-2015-ACL-AOA-CS-0094

The purpose of this Funding Opportunity Announcement (FOA) is to bring to scale and sustain evidence-based self-management education programs that empower older adults and adults with disabilities from underserved areas and populations to better manage their chronic conditions. The grants are intended to increase the number of chronic disease self-management education program participants, while concurrently increasing the sustainability of these proven programs through innovative funding arrangements and by embedding the programs into the nation’s health and long-term services and supports systems. This funding opportunity was announced on April 1, 2015. The application deadline is June 1, 2015. For more information, please visit ACL's Full Funding Opportunity Announcement.

 

ACL: Evidence-Based Falls Prevention Programs

Funding Opportunity Number: HHS-2015-ACL-AOA-FP-0092

The purpose of this Funding Opportunity Announcement (FOA) is to increase the number of older adults and adults with disabilities at risk for falls who participate in evidence-based community programs to reduce falls and falls risk, while concurrently increasing the sustainability of these programs through innovative funding arrangements. The awards will be made in the form of cooperative agreements because AoA will be substantially involved. This funding opportunity was announced on April 1, 2015. The application deadline is June 1, 2015. For more information, please visit ACL's Full Funding Opportunity Announcement.

 

CDC: Training and Technical Assistance for Health Department Demonstration Projects for Comprehensive Prevention, Care, Behavioral Health, and Social Services for Men Who Have Sex with Men of Color At Risk for and Living with HIV Infection

Funding Opportunity Number: CDC-RFA-PS15-1510

The purpose of this Funding Opportunity Announcement (FOA) is to implement a high-quality training and technical assistance program to strengthen the workforce capacity within health departments and their local collaborative organizations ensuring the optimal planning, implementation, and sustainability of programs and services supported under the companions FOA “Health Department Demonstration Projects for Comprehensive Prevention, Care, Behavioral Health, and Social Services for Men Who Have Sex with Men (MSM) of Color At Risk for and Living with HIV Infection” (FOA CDC-RFA-PS15-1509). Based on a set of core competency categories, this FOA supports the innovative development and delivery of information reflective of the most advanced HIV-related science and practice; state-of-the-art training culminating in a certificate of completion; and tailored technical assistance to facilitate PS15-1509 funded health departments and their local collaborative partners in the provision of comprehensive prevention, care, behavioral health, and social services specifically for MSM of color at risk for and living with HIV. This funding opportunity was announced on March 31, 2015. The application deadline is June 1, 2015. For more information, please visit CDC's Full Funding Opportunity Announcement.

 

CDC: Epicenters for the Prevention of Healthcare Associated Infections (HAI) - Cycle II

Funding Opportunity Number: RFA-CK-15-004

The purpose of this Funding Opportunity Announcement (FOA) is to expand the number of CDC Prevention Epicenters to translate basic epidemiologic and technologic discoveries into new strategies for preventing healthcare-associated transmission of Ebola and/or infectious pathogens (viral or bacterial) that can be spread by mechanisms similar to Ebola. This might include, but is not limited to, project proposals that focus on the effectiveness of personal protective equipment against such pathogens, healthcare worker self-contamination with pathogens, or the role of the healthcare environment in pathogen transmission. This funding opportunity was announced on April 1, 2015. The application deadline is June 1, 2015. For more information, please visit CDC's Full Funding Opportunity Announcement.

 

HRSA: Preventive Medicine Residency with Integrative Health Care Training Program

Funding Opportunity Number: HRSA-15-143

This Funding Opportunity Announcement (FOA) solicits applications for the Preventive Medicine Residency with Integrative Health Care Training Program. The broad goal of the program is to improve the health of communities by increasing the number and quality of preventive medicine physicians who can address public health needs, advance preventive medicine practices, increase access to integrative health care, and increase the integration of these two fields into preventive medicine training and practice. Toward those ends, applicants must propose programs to (1) increase the number of preventive medicine residents and/or improve training for these residents, (2) incorporate evidence-based integrative health care curricula into accredited preventive medicine residency programs, and (3) provide inter-professional training of their preventive medicine residents including training in preventive medicine and integrative health care for other primary care or community-based health care trainees or providers in addition to preventive medicine residents. Funds shall be used to (1) plan, develop, operate, or participate in an accredited residency or internship program in preventive medicine or public health, (2) defray the costs of practicum experiences, as required in preventive medicine programs; and, (3) establish, maintain or improve academic administrative units (including departments, divisions, or other appropriate units) in preventive medicine, and public health; or programs that improve clinical teaching in preventive medicine and public health.  This funding opportunity was announced on March 31, 2015. The application deadline is May 29, 2015. For more information, please visit HRSA's Full Funding Opportunity Announcement.

 

HRSA: National Training and Technical Assistance Cooperative Agreements

Funding Opportunity Number: HRSA-15-140

This Funding Opportunity Announcement (FOA) solicits applications for the National Training and Technical Assistance Cooperative Agreements (NCAs) Program to provide necessary technical and non-financial assistance to potential and existing Health Center Program grantees and look-alikes (hereafter referred to as health centers) nationwide.  The mission of the NCAs is to provide training and technical assistance (T/TA) directly and through collaborative partnerships to support health centers in providing better, more affordable care and improving the health of individuals and communities in accordance with the following priorities: (1) making care safer by reducing harm caused in the delivery of care; (2) ensuring that each person and family is engaged as partners in their care; (3) promoting effective communication and coordination of care; (4) promoting the most effective prevention and treatment practices for the leading causes of mortality; (5) working with communities to promote use of best practices to enable healthy living; and (6) making quality care more affordable and accessible for individuals, families, and the community by developing and spreading new health care delivery models. This FOA will provide specialized national T/TA to health centers in one of the following Target Areas: (1) oral health; (2) health information technology and data; or (3) clinical workforce development. This funding opportunity was announced on March 31, 2015. The application deadline is June 1, 2015. For more information, please visit HRSA's Full Funding Opportunity Announcement.

 

DARPA: Technologies for Host Resilience (THoR)

Funding Opportunity Number: DARPA-BAA-15-21

The purpose of this Broad Agency Announcement (BAA) is to discover host tolerance mechanisms in order to identify a suite of interventions suitable for use in humans to mitigate the deleterious effects of infectious diseases. The Technologies for host Resilience (THoR) is seeking novel methods and technologies to discover and understand these responses in hosts that are resilient when exposed to infectious diseases. Specifically, DARPA aims to discover the fundamental biological relationships that underlie host tolerance to infection in animal populations in order to provide the foundational knowledge required to develop interventions for potential transition into clinical use. This program is organized into three Technical Areas (TAs): (1) identification and characterization of animal hosts with tolerant phenotypes; (2) discovery of biological mechanisms that underlie tolerance; and (3) identification of interventions that utilize tolerance mechanisms with the goal of reducing morbidity and mortality due to infection. This BAA will focus specifically on understanding tolerance mechanisms in prospective animal studies in conjunction with the analysis of retrospective pre-clinical and human clinical datasets. This funding opportunity was announced on March 31, 2015. The application deadline is May 19, 2015. For more information, please visit The Army's Full Funding Opportunity Announcement.

 

NIH Funding Opportunity Announcements:

 

NIH: Secondary Analyses in Obesity, Diabetes and Digestive and Kidney Diseases

Funding Opportunity Number: PA-15-169

This Funding Opportunity Announcement (FOA) solicits applications that propose to conduct secondary analyses of existing data sets relevant to diabetes and selected endocrine and metabolic diseases, including thyroid, parathyroid, and Cushings diseases and acromegaly; as well as genetic metabolic diseases, including cystic fibrosis, lysosomal storage diseases, and disorders of the urea cycle, amino acid metabolism and metal transport where the focus is on peripheral metabolism or organ function; obesity, liver diseases, alimentary GI tract diseases and nutrition, and kidney, urologic, and hematologic diseases. The goal of this program is to facilitate research that explores innovative hypotheses through the use of existing data sets. This funding opportunity was announced on April 1, 2015. The initial application deadline is June 16, 2015. For more information, please visit NIH's Full Funding Opportunity Announcement.

 

NIH: New Directions in Hematology Research (SHINE-II)

Funding Opportunity Number: PAS-15-168

This Funding Opportunity Announcement (FOA) is intended to promote innovative research initiatives that explore high impact, new directions of inquiry relevant to the hematology research mission of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). NIDDK invites investigator-initiated grant applications for basic or pre-clinical, proof of principle research projects that are tightly focused and directed at validating novel concepts and approaches that promise to open up new pathways for discovery. Research applications submitted under this FOA should be more limited in scope (a single central aim) and duration (1-3 years) than typical grant applications. This funding opportunity was announced on April 1, 2015. The initial application deadline is June 5, 2015. For more information, please visit NIH's Full Funding Opportunity Announcement.

 

NIH: NIAMS Clinical Trial Implementation Cooperative Agreement

Funding Opportunity Number: PAR-15-165

This Funding Opportunity Announcement (FOA) invites cooperative agreement applications for the implementation of investigator-initiated interventional clinical trials. The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) expects such trials to be hypothesis driven, milestone-defined, related to the research mission of the NIAMS, and considered high-priority by the institute. This funding opportunity was announced on March 31, 2015. The initial application deadline is July 1, 2015. A letter of intent is due 30 days prior to the associated application deadline. For more information, please visit NIH's Full Funding Opportunity Announcement.

 

NIH: NIAMS Clinical Trial Planning Cooperative Agreement

Funding Opportunity Number: PAR-15-166

This Funding Opportunity Announcement (FOA) will support planning grants for investigator-initiated clinical interventional trials. Planning grants are designed to permit the necessary planning, design, and preparation of documentation prior to implementation of investigator-initiated clinical trials. Completion of the planning grant’s agreed upon milestones is recommended prior to submission of an application for a clinical trial implementation grant to support the actual implementation and conduct of the study. The trials must be hypothesis-driven, milestone-defined, related to the research mission of the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) and considered high priority by the Institute. This funding opportunity was announced on March 31, 2015. The initial application deadline is July 1, 2015. A letter of intent is due 30 days prior to the associated application deadline. For more information, please visit NIH's Full Funding Opportunity Announcement.

 

NIH: Clinical Trials to Test the Effectiveness of Treatment, Preventive, and Services Interventions

Funding Opportunity Number: RFA-MH-16-420

This Funding Opportunity Announcement (FOA) seeks to support investigator-initiated clinical trials to establish the effectiveness of interventions and to test hypotheses regarding moderators, mediators, and mechanisms of action of these interventions. This FOA supports clinical trials designed to test the therapeutic value of treatment and preventive interventions for which there is already evidence of efficacy, for use in community and practice settings. Applications might include research to evaluate the effectiveness or increase the clinical impact of pharmacologic, somatic, psychosocial (psychotherapeutic, behavioral), device-based, rehabilitative and combination interventions to prevent or treat mental illness. This FOA also supports clinical trials to test patient, provider, organizational, or systems level services interventions to improve service access, engagement, quality, coordination, or delivery, with the goal of improved outcomes at the individual and population level. The intervention research covered under this FOA is explicitly focused on practice-relevant questions. This funding opportunity was announced on March 30, 2015. The initial application deadline is June 15, 2015. A letter of intent is due 30 days prior to the associated application deadline. For more information, please visit NIH's Full Funding Opportunity Announcement.

 

NIH: Exploratory Clinical Trials of Novel Interventions for Mental Disorders

Funding Opportunity Number: RFA-MH-16-400

The purpose of this Funding Opportunity Announcement (FOA) is to support the efficient pilot testing of novel interventions for mental disorders in adults and children through an experimental therapeutics approach. Under this FOA, trials must be designed so that results, whether positive or negative, will provide information of high scientific utility and will support go/no-go decisions about further development or testing of the intervention. Studies of novel interventions include, but are not limited to, behavioral, pharmacological, biologics-based, cognitive, device-based, interpersonal, physiological, or combined approaches. Support will be provided for testing and validating the interventions ability to affect a specified target, and for relating the change in target to functional or clinical effects. Ultimately, this FOA is intended to speed the translation of emerging basic science findings of mechanisms and processes underlying mental disorders into novel interventions that can be efficiently tested for their promise in restoring function and reducing symptoms for those living with mental disorders. This funding opportunity was announced on March 30, 2015. The initial application deadline is June 15, 2015. A letter of intent is due 30 days prior to the associated application deadline. For more information, please visit NIH's Full Funding Opportunity Announcement.

 

NIH: Exploratory Clinical Trials of Novel Interventions for Mental Disorders

Funding Opportunity Number: RFA-MH-16-405

The purpose of this Funding Opportunity Announcement (FOA) is to support the efficient pilot testing of novel interventions for mental disorders in adults and children through an experimental therapeutics approach. Under this FOA, trials must be designed so that results, whether positive or negative, will provide information of high scientific utility and will support go/no-go decisions about further development or testing of the intervention. Studies of novel interventions include, but are not limited to behavioral, pharmacological, biologics-based, cognitive, device-based, interpersonal, physiological, or combined approaches. Support will be provided for up to two years for preliminary milestone-driven testing and validating of the interventions therapeutic target, possibly followed by up to 3 years of support for studies relating change in the intervention target to functional or clinical effects. Ultimately, this FOA is intended to speed the translation of emerging basic science findings of mechanisms and processes underlying mental disorders into novel interventions that can be efficiently tested for their promise in restoring function and reducing symptoms for those living with mental disorders. This funding opportunity was announced on March 30, 2015. The initial application deadline is June 15, 2015. A letter of intent is due 30 days prior to the associated application deadline. For more information, please visit NIH's Full Funding Opportunity Announcement.

 

NIH: Clinical Trials to Test the Effectiveness of Treatment, Preventive and Services Interventions

Funding Opportunity Number: RFA-MH-16-415

The purpose of this Funding Opportunity Announcement (FOA) is to support collaborative research to test the therapeutic value of treatment, preventive, and services strategies for which there is already evidence of efficacy, for use in community and practice settings and to test hypotheses regarding moderators, mediators, and mechanisms of action of these interventions. This FOA supports research to evaluate the effectiveness of pharmacologic, psychosocial (psychotherapeutic and behavioral), rehabilitative and combination interventions that show promise, compared to existing treatment approaches, for improving symptomatic and functional outcomes for mental disorders. Studies that address either acute or longer-term therapeutic effects are encouraged. This FOA also supports clinical trials to test patient, provider, organizational, or systems level services interventions to improve service access, engagement, quality, coordination, or delivery, with the goal of improved outcomes for individual patients and as well as larger populations. The intervention research covered under this announcement is explicitly focused on practice-relevant questions. This FOA is intended to support research on interventions/services models that have the potential to substantially impact practice and public health in terms of the magnitude of likely improvements in key outcomes (e.g., clinical benefit, safety/tolerability profile, value and efficiency, or scalability potential), as compared to existing approaches. This funding opportunity was announced on March 30, 2015. The initial application deadline is June 15, 2015. A letter of intent is due 30 days prior to the associated application deadline. For more information, please visit NIH's Full Funding Opportunity Announcement.

 

NIH: Pilot Effectiveness Trials for Treatment, Preventive and Services Interventions

Funding Opportunity Number: RFA-MH-16-410

The purpose of this Funding Opportunity Announcement (FOA) is to encourage pilot research consistent with the National Institute of mental Health (NIMH) priorities for (1) effectiveness research on preventive and therapeutic interventions with previously demonstrated efficacy, for use with broader target populations or for use in community practice settings, and (2) research on the development and preliminary testing of innovative services interventions. Applications should provide resources for evaluating the feasibility, tolerability, acceptability and safety of approaches to improve mental health or functional outcomes, or modify risk factors, and for obtaining the preliminary data needed as a pre-requisite to a larger-scale intervention trial (e.g., comparative effectiveness study, practical trial) or large-scale services study. In this pilot phase of effectiveness research, NIMH places highest priority on approaches that can be justified in terms of their potential to substantially impact practice and public health and approaches that are empirically grounded. Adaptations or augmentations of efficacious interventions should only be undertaken if there is an empirical rationale for the adaptation target and for the corresponding mechanism by which the adapted intervention or augmentation is expected to substantially enhance outcomes. This FOA is intended to support pilot effectiveness trials that are designed to explicitly address whether the intervention engages the target/mechanism that is presumed to underlie the intervention effects. This funding opportunity was announced on March 30, 2015. The initial application deadline is June 15, 2015. A letter of intent is due 30 days prior to the associated application deadline. For more information, please visit NIH's Full Funding Opportunity Announcement.

 

NIH: Confirmatory Efficacy Clinical Trials of Non-Pharmacological Interventions for Mental Disorders

Funding Opportunity Number: RFA-MH-16-425

The purpose of this Funding Opportunity Announcement (FOA) is to support confirmatory efficacy testing of non-pharmacological therapeutic and preventive interventions for mental disorders in adults and children through an experimental therapeutics approach. Under this FOA, trials must be designed so that results, whether positive or negative, will provide information of high scientific utility and will support "go/no-go" decisions about further development, effectiveness testing, or dissemination of the intervention. Intervention studies include, but are not limited to behavioral, cognitive, interpersonal, and device-based approaches, or a combination thereof. Interventions appropriate for efficacy testing must be based on a compelling scientific rationale, previous demonstration that the intervention engages and alters the hypothesized mechanism of action, a preliminary efficacy signal, and must address an unmet therapeutic need. Support will be provided for a trial of the intervention's efficacy that includes measurement of the hypothesized mechanism of action and the relationship between change in the mechanism and change in functional or clinical effects. Ultimately, this FOA is intended to support a sufficiently powered efficacy trial to determine the intervention's potential for significant clinical benefit. This funding opportunity was announced on March 30, 2015. The initial application deadline is June 15, 2015. A letter of intent is due 30 days prior to the associated application deadline. For more information, please visit NIH's Full Funding Opportunity Announcement.

 

 

NIH: HIV Vaccine Research and Design (HIVRAD) Program

Funding Opportunity Number: PAR-15-164

The HIV Vaccine Research and Design (HIVRAD) program is designed to fund projects that further address hypotheses crucial to the design of an efficacious HIV/AIDS prophylactic vaccine. Applications for five years of support should include plans that have advanced past the exploratory stage and include preliminary data. Less fully developed applications can request less than 5 years of support to establish feasibility. Applications aimed at developing or optimizing a specific vaccine platform should lay out a research pathway with clear decision points. Extensive modeling of vaccine concepts in non-human primates may be included. This funding opportunity was announced on March 31, 2015. The initial application deadline is July 15, 2015. A letter of intent is due 30 days prior to the associated application deadline. For more information, please visit NIH's Full Funding Opportunity Announcement.

 

NIH: NIBIB Research Education Programs for Residents and Clinical Fellows

Funding Opportunity Number: PAR-15-167

The NIH Research Education Program supports research education activities in the mission areas of the NIH. The overarching goal of this National Institute of Biomedical Imaging and Bioengineering (NIBIB) program is to complement and/or enhance the training of a workforce to meet the nation’s biomedical, behavioral, and clinical research needs. Specifically, it intends to support research experiences for residents and/or clinical fellows in Radiology or other NIBIB-relevant clinical programs to support their career development and to foster their career as clinician-scientists. Program participants must be residents and/or clinical fellows in programs including, but not limited to, cardiology, neurology, nuclear medicine, ophthalmology, orthopedics, radiology, or surgery. This funding opportunity was announced on April 1, 2015. The initial application deadline is June 9, 2015. A letter of intent is due 30 days prior to the associated application deadline. For more information, please visit NIH's Full Funding Opportunity Announcement.

 

NIH: Diet and Physical Activity Assessment Methodology

Funding Opportunity Numbers: PAR-15-170 and PAR-15-171

These Funding Opportunity Announcements (FOAs) encourage innovative research to enhance the quality of measurements of dietary intake and physical activity. Applications are encouraged to address the development of (1) novel assessment approaches, (2) better methods to evaluate instruments, (3) assessment tools for culturally diverse populations or various age groups, including children and older adults, (3) improved technology or applications of existing technology, (4) statistical methods/modeling to improve assessment and/or to correct for measurement errors or biases, (5) methods to investigate the multidimensionality of diet and physical activity behavior through pattern analysis (6) or integrated measurement of diet and physical activity along with the environmental context of such behaviors. These funding opportunities were announced on April 2, 2015. The initial application deadline for PAR-15-170 is October 5, 2015. The initial application deadline for PAR-15-171 is October 16, 2015. A letter of intent for each funding opportunity is due 30 days prior to the associated application deadline. For more information, please visit NIH's Full Funding Opportunity Announcements for PAR-15-170 and PAR-15-171.

 

NIH: Alzheimer's Drug-Development Program

Funding Opportunity Number: PAR-15-174

The goal of this Funding Opportunity Announcement (FOA) is to provide funding support for the pre-clinical and early stage (Phase I) clinical development of small-molecule and biologic therapeutic agents that prevent Alzheimer's disease (AD), slow its progression, or treat its cognitive and behavioral symptoms. Participants in this program will receive funding for therapy development activities such as (1) medicinal chemistry, (2) pharmacokinetics (PK), (3) absorption, distribution, metabolism, excretion, toxicology (ADMET), (4) efficacy in animal models, (5) formulation development, (6) chemical synthesis under Good Manufacturing Practices (GMP), (7) Investigational New Drug (IND) enabling studies, and (8) initial Phase I clinical testing. This program does not support research on basic mechanisms of disease, development of biomarkers, devices, non-pharmacological interventions (e.g., exercise, diet, cognitive training), repurposed drugs and combinations therapies or, discovery activities such as high throughput screening and hit optimization. This funding opportunity was announced on April 2, 2015. The initial application deadline is June 5, 2015. A letter of intent is due 30 days prior to the associated application deadline. For more information, please visit NIH's Full Funding Opportunity Announcement.

 

NIH: Pre-Application for Collaborative Innovation Award, CTSA Program

Funding Opportunity Number: PAR-15-173

Translating biomedical discoveries into clinical applications is essential to improving human health. It is also a complex process with high costs and substantial failure rates. These failures can result in delays of years or decades before improved patient outcomes result from discoveries in biomedical research. The Clinical and Translational Science Award (CTSA) hubs promote advances in translational research and training at participating medical research institutions. This Funding Opportunity Announcement (FOA) encourages pre-applications for innovative collaborative investigations (involving three or more CTSA sites) into improvements of the methods of translational research, at any step in the translational spectrum.  It is anticipated that the combined effort of three or more CTSA hubs in flexible networks will substantially enhance the effectiveness of the CTSA consortium to address high priority translational research questions. The program therefore aims to support innovative and collaborative experimental translational research projects carried out in the CTSA consortium. This funding opportunity was announced on April 2, 2015. A letter of intent is due by May 24, 2015. The initial application deadline is June 24, 2015. For more information, please visit NIH's Full Funding Opportunity Announcement.

 

NIH: Regional Medical Libraries for the National Network of Libraries of Medicine

Funding Opportunity Number: RFA-LM-15-003

This Funding Opportunity Announcement (FOA) solicits applications for Regional Medical Libraries (RMLs) as an integral component of the National Network of Libraries of Medicine (NN/LM). The goal of the NN/LM is to advance the progress of medicine and improve public health by providing U.S. health professionals with equal access to biomedical information and improving individual's access to information to enable them to make informed decisions about their health. Eight Health Sciences Libraries will function as the RML for their respective region. The RMLs will coordinate the operation of a Network of Libraries and other organizations to carry out regional and national programs. The RMLs will ensure a continuity of quality service for core programs of the NN/LM, and cooperatively design, implement and evaluate innovative approaches to serve the health information needs of health professionals and the public in the future. This funding opportunity was announced on April 2, 2015. A letter of intent is due by June 24, 2015. The initial application deadline is July 24, 2015. For more information, please visit NIH's Full Funding Opportunity Announcement.

 

NIH: Phenotypic and Functional Studies on FOXO3 Human Longevity Variants to Inform Potential Therapeutic Target Identification Research

Funding Opportunity Number: PAR-15-175

The focus of this Funding Opportunity Announcement (FOA) is in vivo human studies and in vitro studies on human cells or tissues, aimed at potential identification of therapeutic targets or and/or testing of interventions for healthy aging. Potential therapeutic targets include FOXO3 itself and upstream and downstream regulators in pathways mediated by FOXO3. The range of research areas of interest in this FOA includes studies that (1) examine in vivo phenotypic effects of human FOXO3 variants, (2) elucidate effects of these variants on cellular functions and the pathways that mediate them, and/or (3) identify and evaluate candidate therapeutic targets (e.g., target validation studies, testing of candidate compounds) for potential interventions based on FOXO3 functional pathways. This funding opportunity was announced on April 2, 2015. The initial application deadline is June 5, 2015. For more information, please visit NIH's Full Funding Opportunity Announcement.

 

NIH: Collaborative Innovation Award, Clinical and Translational Science Award (CTSA) Program

Funding Opportunity Number: PAR-15-172

The purpose of this Funding Opportunity Announcement (FOA) is to invite applications to stimulate innovative collaborative research in the National Center for Advancing Translational Sciences (NCATS) Clinical and Translational Science Award (CTSA) consortium. Translating biomedical discoveries into clinical applications is essential to improving human health. It is also a complex process with high costs and substantial failure rates. These failures can result in delays of years or decades before improved patient outcomes result from discoveries in biomedical research. The Clinical and Translational Science Award (CTSA) hubs promote advances in translational research and training at participating medical research institutions.  This FOA will enable innovative collaborations among CTSA hubs to overcome system-wide barriers to translational effectiveness. This funding opportunity was announced on April 2, 2015. The initial application deadline is February 3, 2016. For more information, please visit NIH's Full Funding Opportunity Announcement.

 

NIH: Oral Immune System Plasticity in Chronic HIV Infection Under Treatment and Oral Co-Infections

Funding Opportunity Number: RFA-DE-16-002

This Funding Opportunity Announcement (FOA) solicits research projects that study the mechanisms of oral immune system plasticity relevant to chronic HIV infection and oral co-infections. In this context, we encourage studies on reversal of immune activation, residual inflammation, immune reconstitution inflammatory syndrome (IRIS), and microbial and by-product translocation. These conditions occur in persons chronically infected with HIV who are treated with combination antiretroviral therapy (cART) and who also experience oral opportunistic infections. The ultimate goals of this FOA are (1) to gain knowledge regarding the pathogenesis and persistence of these oral conditions and (2) to guide the development of novel oral immune modulatory therapies that will aid in re-building the oral immune system to reverse these diseases, mitigate their progression, prevent their occurrence, and eliminate persistence of residual HIV and other oral pathogens in reservoirs. This funding opportunity was announced on April 3, 2015. A letter of intent is due by September 29, 2015. The initial application deadline is October 29, 2015. For more information, please visit NIH's Full Funding Opportunity Announcement.

 

NIH: Lifespan Human Connectome Project: Baby Connectome

Funding Opportunity Number: RFA-MH-16-160

This Funding Opportunity Announcement (FOA) is issued as an initiative of the NIH Blueprint for Neuroscience Research (Neuroscience Blueprint). The Neuroscience Blueprint is a collaborative framework through which 15 NIH Institutes, Centers, and Offices jointly support neuroscience-related research, with the aim of accelerating discoveries and reducing the burden of nervous system disorders. The Neuroscience Blueprint is supporting a Lifespan Human Connectome Project (L-HCP) to extend the Human Connectome Project (HCP) to map connectivity in the developing, adult, and aging human brain. The goal of this FOA is to solicit applications that propose to extend the experimental protocols developed through the HCP to children in the 0-5 year old age range to investigate the structural and functional changes that occur in the brain during typical development. Related FOAs solicit applications that apply the HCP protocols to the 5-21 year old age range and to middle age and elderly adults to explore changes that occur during normal aging. This funding opportunity was announced on April 3, 2015. A letter of intent is due by August 3, 2015. The application deadline is September 3, 2015. For more information, please visit NIH's Full Funding Opportunity Announcement.


Association Management Software Powered by YourMembership  ::  Legal